Carlsbad’s leading pharmaceutical company Isis announced today that they only lost $7 million dollars this quarter compared to a lost of $14.1 million in 2007.
Isis’ full-year loss after preferred dividends widened to $136.3 million, or $1.63 per share compared with a loss of $45.9 million, or 62 cents per share, in the previous year. The company said $1.50 of the 2007 per-share loss was attributable to the $120 million purchase of Symphony GenIsis.
There are millions in this business somewhere.
[Link: Forbes.com]
{ 0 comments… add one now }